# A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

> **NCT00287521** · PHASE2 · COMPLETED · sponsor: **Alcon Research** · enrollment: 87 (actual)

## Conditions studied

- Open-angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** AL-37807 Ophthalmic Suspension, 1.0%
- **DRUG:** Latanoprost, 0.005% (Xalatan)
- **OTHER:** AL-37807 Vehicle
- **DRUG:** Timolol Maleate Ophthalmic Gel Forming Solution, 0.5%

## Key facts

- **NCT ID:** NCT00287521
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2012-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00287521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00287521, "A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00287521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*